Source: ERJ Open Res, 6 (4) 00135-2020; 10.1183/23120541.00135-2020
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gustavo Nino, Carlos E. Rodríguez-Martínez, Jose A. Castro-Rodriguez. The use of ß₂-adrenoreceptor agonists in viral bronchiolitis: scientific rationale beyond evidence-based guidelines. ERJ Open Res, 6 (4) 00135-2020; 10.1183/23120541.00135-2020

Member's Comments

No comment yet.

Related content which might interest you: Cough clinical practice guidelines: A critical review of scientific evidence and recommendations Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 How do the new guidelines work? Practical approach to the new guidelines for asthma diagnosis in children, discussion and Q&A Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years Year: 2021 Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a case in point Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008 How to apply evidence based practice critique method to review of guidelines Source: Annual Congress 2005 - Workshop: evidence-based practice: an approach to care Year: 2005 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 The new ATS/ERS/IDSA/CDC guidelines for MDR-TB: rationale, methods and recommendations Source: International Congress 2019 – Managing drug-resistant tuberculosis: from new guidelines to clinical practice Year: 2019 Respiratory medicines for children: current evidence, unlicensed use and research priorities Source: Eur Respir J 2010; 35: 247-265 Year: 2010 Current management of acute bronchiolitis in Switzerland after implementation of new guidelines in 2003 Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 What is the difference between an evidence-based guideline and a consensus statement? Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP) Year: 2006 Use and misuse of clinical and evidence-based guidelines in clinical practice Source: Annual Congress 2009 - Physiotherapy for the respiratory patient: evidence-based guidelines Year: 2009 Adaptation rate between COPD treatment in clinical practice and guidelines recommendations Source: Eur Respir J 2007; 30: Suppl. 51, 779s Year: 2007 2015 guidelines to treat IPF: an update of the 2011 guidelines - specific treatment recommendations Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis Year: 2015 Developing evidence-based recommendations regarding inhalation technique in patients with COPD Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 The new WHO air quality guidelines: policy and clinical implications for children with respiratory diseases Source: Virtual Congress 2021 – The environment and climate change effects on lung health across the lifecourse Year: 2021 Revising our approach to conducting therapeutic clinical research in COPD Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017 Year: 2018 Translating research into practice: how are guidelines implemented? Source: Eur Respir J 2003; 21: 23S-29S Year: 2003 Developing a patient-centred template for asthma reviews: an IMP2ART implementation strategy Source: International Congress 2019 – Innovations in primary care assessment and management Year: 2019 An evidence-based, point-of-care tool to guide completion of asthma action plans in practice Source: Eur Respir J, 49 (5) 1602238; 10.1183/13993003.02238-2016 Year: 2017 How does one develop an evidence-based guideline? Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP) Year: 2006